The Predictive Value of an Ultrasound Quantitative Scoring System for Treatment Method Selection in Patients With Caesarean Scar Pregnancy: A Single-Centre Retrospective Study
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 117
- Locations
- 1
- Primary Endpoint
- intraoperative blood loss
Study Overview
Brief Summary
This study uses a systematic scoring method combined with clinical and ultrasound data to comprehensively evaluate patient conditions and explore the guiding value of the ultrasound quantitative scoring system for selecting the surgical approach for caesarean scar pregnancy.
Study Design
- Study Type
- Observational
- Observational Model
- Case Control
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 20 Years to — (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •history of at least one previous caesarean section
- •symptoms suggestive of caesarean scar pregnancy, such as unexplained abnormal vaginal bleeding, abdominal pain, cervical pain or abnormal uterine activity during pregnancy
- •amenorrhea ≤84 days
- •ultrasound examination suggesting a single gestational sac with intact morphology
- •stable maternal vital signs
Exclusion Criteria
- •mass-type caesarean scar pregnancy
- •previous medication or surgical treatment before ultrasound examination
- •haemodynamically unstable patients
- •patients with surgical contraindications
- •incomplete or lost follow-up clinical data
- •patients with severe medical conditions such as hypertension, diabetes, hyperthyroidism and haemophilia
Outcomes
Primary Outcomes
intraoperative blood loss
Time Frame: during surgery
The patient's blood loss during surgery. Check the blood volume in ml of the aspirator reservoir.
serum β-HCG levels
Time Frame: Within 2 weeks after the operation
The time taken for serum β-HCG levels to return to normal
length of hospital stay
Time Frame: Within 1 week
Number of days the patient was hospitalized. Discharge assessment: vital signs stable, no abdominal pain, no active bleeding.
Secondary Outcomes
No secondary outcomes reported
Investigators
Jianwen Du
physician
Chengde Central Hospital